Thomas Lohnes/Getty Images News BioNTech (NASDAQ:BNTX) announced Tuesday that its mRNA-based cancer therapy BNT111, in
Jeenah Moon/Getty Images News Pfizer (NYSE:PFE) shares gained 4.1% premarket Tuesday after the company topped
Summary: BioNTech’s revenue soared during the COVID era, but the company faces uncertainty with declining
Summary: BioNTech is a biotech company with a strong cash position and a commercial program
Summary: BioNTech is expected to report a significant decline in sales for the first quarter,
Summary: BioNTech’s Q4 earnings shows a significant revenue drop and profitability concerns, with expectations of
Summary: BioNTech and Autolus have announced a strategic alliance to advance their autologous CAR-T programs
Summary: BioNTech is diversifying its portfolio beyond its COVID-19 vaccine, focusing on antibody-drug conjugates (ADCs)
Summary: BioNTech and Pfizer’s COVID-19 vaccine, COMIRNATY, generated $36.8 billion in sales in 2021, making